Outcomes associated with adjuvant radiation after lumpectomy for elderly women with T1-2N0M0 triple-negative breast cancer: SEER analysis.

被引:1
|
作者
Szeja, Sean
Hatch, Sandra S.
机构
[1] UTMB Galveston, Galveston, TX USA
[2] UTMB, Galveston, TX USA
关键词
D O I
10.1200/jco.2015.33.28_suppl.39
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
39
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Outcomes in postmenopausal women with T2N0 breast cancer without adjuvant chemotherapy
    Kim, J. W.
    Kim, Y. S.
    Ko, B. S.
    Kim, K. C.
    [J]. BREAST, 2015, 24 : S60 - S60
  • [32] Benefit of Adjuvant Radiotherapy After Breast-Conserving Therapy Among Elderly Women With T1-T2N0 Estrogen Receptor-Negative Breast Cancer
    Eaton, Bree R.
    Jiang, Renjian
    Torres, Mylin A.
    Kahn, Shannon T.
    Godette, Karen
    Lash, Timothy L.
    Ward, Kevin C.
    [J]. CANCER, 2016, 122 (19) : 3059 - 3068
  • [34] Risk factors for axillary lymph node metastases in clinical stage T1-2N0M0 breast cancer patients
    Zhang, Yuanxin
    Li, Ji
    Fan, Yuan
    Li, Xiaomin
    Qiu, Juanjuan
    Zhu, Mou
    Li, Hongjiang
    [J]. MEDICINE, 2019, 98 (40)
  • [35] Increased Risk of Locoregional Recurrence for Women With T1-2N0 Triple-Negative Breast Cancer Treated With Modified Radical Mastectomy Without Adjuvant Radiation Therapy Compared With Breast-Conserving Therapy
    Abdulkarim, Bassam S.
    Cuartero, Julie
    Hanson, John
    Deschenes, Jean
    Lesniak, David
    Sabri, Siham
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (21) : 2852 - 2858
  • [37] Prognostic Value of Epithelial Cell Adhesion Molecules in T1-2N0M0 Glottic Cancer
    Murakami, Naoya
    Mori, Taisuke
    Machida, Ryunosuke
    Kodaira, Takeshi
    Ito, Yoshinori
    Shikama, Naoto
    Konishi, Koji
    Matsumoto, Yasuo
    Murakami, Yuji
    Nakamura, Naoki
    Yamashita, Hideomi
    Yorozu, Atsunori
    Yoshimura, Michio
    Inoue, Koichi
    Nozaki, Miwako
    Ishikura, Satoshi
    Itami, Jun
    Nishimura, Yasumasa
    Kagami, Yoshikazu
    [J]. LARYNGOSCOPE, 2021, 131 (07): : 1522 - 1527
  • [38] Does T1c-2N0-1M0 triple negative breast cancer derive a benefit from neoadjuvant chemotherapy?
    Zhang, Jie
    Yu, Yushuai
    Chen, Weiwei
    Fu, Wenfen
    Chen, Ruiliang
    Yi, Jialu
    Song, Chuangui
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [39] Breast Conservation Therapy Achieved Comparable Outcomes with Mastectomy in Patients with T1-2N0 Triple-Negative Breast Cancer: Analysis of 822 Patients in a Single Institution
    Wang, S.
    Tang, Y.
    Fang, H.
    Sun, G.
    Jing, H.
    Song, Y. W.
    Wang, J.
    Jin, J.
    Liu, Y.
    Ren, H.
    Yu, Z.
    Li, Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E594 - E594
  • [40] Risk of local-regional and distant recurrence in triple-negative T1N0 breast cancer
    Malmgren, J. A.
    Atwood, M. K.
    Kaplan, H. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)